GL1X · GenesisL1 explorer

Research workbench

Vaccinia methyltransferase VP39 mutant D182A complexed with M7G and S- adenosylhomocysteine

Analyse Vaccinia methyltransferase VP39 mutant D182A complexed with M7G and S… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4DCG
Type
protein
Length
291 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
VP39
EC
2.7.7.19
UniProt
P07617
Ligands
SAH, MG7
Pockets
4 · best druggability 0.47

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVP39 (EC 2.7.7.19)protein29141% helix, 17% strandP07617

Ligands and binding sites

  • SAH · S-adenosyl-L-homocysteine · ligand · chains A
  • MG7 · 7-methylguanosine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11640.470.7637MG7
2870.370.7620empty
3860.360.7513empty
4770.350.7624SAH

Compared structures

  • 4DCG · Vaccinia methyltransferase VP39 mutant D182A complexed with M7G and S-adenosylhomocysteine · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.